Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate |
1997-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfcac62de3353088a07a628977815f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fc62e2d65486d62ac7bbe8d6606c9b6 |
publicationDate |
1999-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0892641-A1 |
titleOfInvention |
Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours |
abstract |
The invention concerns the use of compounds with anti-glucocorticoid activity with the exception of mifepristone for preparing medicine for the prevention or treatment of psychoses or addictive behaviour. |
priorityDate |
1996-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |